Byline: Will Doss
-
Transforming Lung Cells Critical for Pulmonary Fibrosis
The failure of epithelial cells to complete a stem cell-like transition may lead to pulmonary fibrosis, according to a Northwestern Medicine study.
-
Krainc to receive $9 Million, 8-year NIH Grant
Dimitri Krainc, MD, PhD, has received a Research Program Award grant from the National Institute of Neurological Disorders and Stroke (NINDS).
-
New Center for Pathogen Genomics and Microbial Evolution
The Institute for Global Health (IGH) has established the Center for Pathogen Genomics and Microbial Evolution which will apply lessons learned during the COVID-19 pandemic to the tracking and prevention of future threats.
-
Mitochondria Play Key Role in Lymphatic Development
Mitochondria play a key role in forming the lymphatic vasculature by acting as a metabolic sensor during the migration of lymphatic progenitor cells from the veins.
-
Northwestern Investigators Pursue Strategies to Combat COVID-19
Northwestern Medicine scientists and clinicians have continued to investigate methods to combat the disease, including strategies to conduct clinical trials during a pandemic, studying neurologic symptoms in children and reflecting on the importance of professional medical organizations during a public health crisis.
-
Ahya Honored with Service Award from National Kidney Foundation
Shubhada Ahya, MD, has received the Medical Advisory Board Distinguished Service Award from the National Kidney Foundation.
-
Transporter Imbalance Implicated in Schizophrenia
Alterations in the balance of two chloride transporters may be responsible for cognitive deficits in schizophrenia, according to a Northwestern Medicine study.
-
Mitochondria Could Boost Immunotherapy Effectiveness
Boosting mitochondrial function in a subpopulation of T cells could make cancer immunotherapy more effective, according to a recent study.
-
Uncovering the Function of Prostate Cancer Protein
Northwestern Medicine scientists have discovered a mechanism that makes a prostate cancer-causing protein called FOXA1 more resilient, according to a recent study.
-
Gender-Affirming Treatment Impacts Cholesterol Levels
Gender-affirming hormone treatment caused cholesterol levels to increase for people designated male at birth and decrease for people designated female at birth, according to a recent study.
